Dividend stocks in the Dow Jones Industrial Average provide investors with yields ranging from 2.9% to 6.8% across multiple sectors. These companies span telecom, energy, healthcare, consumer staples, and real estate industries.
Investment experts caution that high yields alone do not guarantee returns. Investors must examine business fundamentals and ensure dividend stocks match their risk tolerance and portfolio goals.
Verizon offers the highest Dow dividend yield at 6.8%. The telecom company benefits from steady customer retention as most subscribers maintain their service for years.
Verizon Communications Inc., VZ
The company carries substantial debt from network operations that require constant upgrades. Verizon’s dividend growth averaged just 2% annually over the past decade.
This growth rate trails historical inflation levels. The company appointed a new CEO to improve growth prospects.
The stock trades around $41 per share. Twelve analysts rate it a “Buy” with an average price target of $48.50.
Scotiabank cites subscriber additions as a positive factor. The firm maintains a “Sector Perform” rating on the stock.
Chevron provides a 4.6% yield backed by 37 consecutive years of dividend increases. This streak stands out in the volatile energy sector.
Chevron Corporation, CVX
The company operates across upstream production, midstream pipelines, and downstream refining. This integrated model helps smooth industry cycles.
Chevron maintains a debt-to-equity ratio of 0.22. The strong balance sheet gives management flexibility during downturns.
The company can borrow to fund operations when oil prices fall. When prices recover, Chevron reduces leverage for the next cycle.
The stock trades near $152 per share. Seventeen analysts rate it a “Buy” with an average target of $172.
HSBC set a $169 target highlighting share buyback programs. Wells Fargo maintains a $196 target on the stock.
Merck yields 3.4% and ranks among the world’s largest pharmaceutical companies. The stock trades around $100 after climbing 41% over six months.
Merck & Co., Inc., MRK
The company faces patent expirations on key drugs in coming years. Patent cliffs can hurt revenues when blockbuster drugs lose protection.
Merck’s dividend payout ratio sits around 45%. This leaves room to maintain payments during the patent transition period.
Keytruda generates over $25 billion in annual sales. Thirteen analysts rate the stock a “Buy” with a $107 average target.
J.P. Morgan set a $120 price target based on HIV pipeline developments. Goldman Sachs raised its target to $120 reflecting improved valuation metrics.
Johnson & Johnson yields 3.0% with 62 consecutive years of dividend increases. The healthcare giant trades around $206, up 14% year-to-date.
Its oncology products drive current growth. The medical device division adds revenue stability to the business.
Fifteen analysts rate the stock a “Buy” with an average price target of $198. Guggenheim analyst Vamil Divan raised his target to $227.
Barclays maintains an “Equal-Weight” rating at $197. The firm projects earnings per share of $10.86 in 2025.
Coca-Cola delivers a 2.9% yield backed by 63 years of dividend growth. The stock trades near $73 with gains from emerging markets.
Thirteen analysts give the stock a “Strong Buy” rating. The average price target sits at $78, representing a 7% potential increase.
UBS holds an $82 target following discussions about the company’s AI strategy. Bank of America set an $80 price target pointing to a 25% increase in net income.
Realty Income yields 5.0% with monthly dividend payments. The real estate investment trust trades around $59 with a portfolio of 15,500 properties.
Thirteen analysts give it a “Hold” rating with a $62 target. Barclays set a $64 price target noting $6 billion in planned 2025 investments.
The REIT focuses on retail properties with long-term leases. These leases are designed to withstand e-commerce pressure on traditional retail spaces.
The post Best Dividend Stocks To Buy In 2026 appeared first on Blockonomi.


